Utility of creatinine/cystatin C ratio as a predictive marker for adverse effects of chemotherapy in lung cancer: A retrospective study

Precision treatment for cancer: Role of prognostic and predictive markers

(2014) Michael J. Duffy et al.   CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES

Management of Anorexia-Cachexia in Late-Stage Lung Cancer Patients

(2012) Catherine Del Ferraro et al.   Journal of Hospice & Palliative Nursing

Sarcopenia Predicts Early Dose-Limiting Toxicities and Pharmacokinetics of Sorafenib in Patients with Hepatocellular Carcinoma

(2012) Olivier Mir et al.   PLoS One

Predicting the risk of chemotherapy toxicity in older patients: The Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) score

(2011) Martine Extermann et al.   CANCER

The PCR-invader method (structure-specific 5′ nuclease-based method), a sensitive method for detecting EGFR gene mutations in lung cancer specimens; comparison with direct sequencing

(2011) Katsuhiko Naoki et al.   International Journal of Clinical Oncology

Predicting Chemotherapy Toxicity in Older Adults With Cancer: A Prospective Multicenter Study

(2011) Arti Hurria et al.   JOURNAL OF CLINICAL ONCOLOGY

Health-related quality of life and cancer clinical trials

(2011) David Osoba   Therapeutic Advances in Medical Oncology

Prevalence and Determinant Factors of Sarcopenia in Patients With Type 2 Diabetes: The Korean Sarcopenic Obesity Study (KSOS)

(2010) T. N. Kim et al.   DIABETES CARE

A Universal Formula Based on Cystatin C to Perform Individual Dosing of Carboplatin in Normal Weight, Underweight, and Obese Patients

(2009) A. Schmitt et al.   CLINICAL CANCER RESEARCH

Sarcopenia in an Overweight or Obese Patient Is an Adverse Prognostic Factor in Pancreatic Cancer

(2009) B. H.L. Tan et al.   CLINICAL CANCER RESEARCH

Sarcopenia as a Determinant of Chemotherapy Toxicity and Time to Tumor Progression in Metastatic Breast Cancer Patients Receiving Capecitabine Treatment

(2009) C. M.M. Prado et al.   CLINICAL CANCER RESEARCH

Influence of Muscle Mass and Physical Activity on Serum and Urinary Creatinine and Serum Cystatin C

(2008) A. C. Baxmann et al.   Clinical Journal of the American Society of Nephrology

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

(2008) E.A. Eisenhauer et al.   EUROPEAN JOURNAL OF CANCER

Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study

(2008) Carla MM Prado et al.   LANCET ONCOLOGY

Sarcopenic obesity: A new category of obesity in the elderly

(2008) Mauro Zamboni et al.   NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES